NCT00015171已完成3 期
CS1008 A&B Eff/Safety Trial of BUP/NX for the Treatment of Opiate Dependence
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 1
- 主要终点
- Craving
研究概览
简要总结
The purpose of this study is the use of buprenorphine/naloxone in treatment of opioid dependence.
详细描述
The objective of this study is to determine the safety and efficacy of a buprenorphine/naloxone combination tablet for opiate dependence treatment.
研究设计
- 研究类型
- Interventional
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 59 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •DSM-IV diagnosis of current opiate dependence males and non-pregnant, non-nursing female 18-59 yrs of age
排除标准
- •Any significant medical condition AST or ALT levels greater than 3x's the upper limit of normal level Current Axis I diagnosis other than opiate, caffeine or nicotine dependence
结局指标
主要结局
Craving
Drug use
Retention
Opioid withdrawal
Subjective rating
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1Opioid-Related DisordersSubstance-Related DisordersNCT00015028National Institute on Drug Abuse (NIDA)
已完成
2 期
Trial of Buprenorphine/Naloxone for Opiate Dependence - 2Opioid-Related DisordersSubstance-Related DisordersNCT00000353National Institute on Drug Abuse (NIDA)
已完成
2 期
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9Opioid-Related DisordersNCT00000344National Institute on Drug Abuse (NIDA)40
撤回
2 期
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1Heroin DependenceOpioid-Related DisordersNCT00000326University of Colorado, Denver
已完成
4 期
Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14Opioid DependenceSubstance-Related DisordersNCT00015340National Institute on Drug Abuse (NIDA)582